Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Leo describes potent vitamin D3 derivatives with low calcemic activity

Sep. 3, 1998

New neurokinin antagonists from Schering-Plough especially useful for asthma

Sep. 3, 1998

Compounds interacting with nicotinic receptors for cognitive and memory deficits

Sep. 2, 1998

Merck & Co. claims glucagon antagonists, cytokine inhibitors

Sep. 2, 1998

Zeneca patents new peptides for autoimmune/inflammatory disorders

Sep. 2, 1998

Anticonvulsant benzamides prepared at SKB

Sep. 2, 1998

Inhibitors of NOS developed at Pfizer

Sep. 2, 1998

Banyu presents urea derivatives with NPY receptor-antagonist activity

Sep. 2, 1998

Novel agents for irritable bowel syndrome in early development at Kyorin

Sep. 1, 1998

Chugai investigates macrolide compounds as prokinetic agents

Sep. 1, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...